Orphan Drug Trial Sponsors ‘Playing Catch-Up’ With Regulators – But Automation Can Help

Clinical trial sponsors in the rare disease space face “big safety demands” from regulators, which can be challenging for those with limited resources. A CRO founder makes the case for “embedding automation” into the clinical trial process to keep pace with regulatory requirements.

Automation can help trial sponsors to meet safety demands, an expert says (Shutterstock)

More from AI

More from Europe